阴道子宫托自我管理对比门诊护理治疗盆腔器官脱垂的四年临床与成本效果(TOPSY):一项随机优效性试验的长期随访
TOPSY试验四年随访比较子宫托自我管理与门诊护理。340例随机,186例(55%)应答。四年时盆底特异性生活质量(PFIQ-7)两组无统计学显著差异(自我管理组均值32.9 vs 门诊护理组31.4,校正均值差4.86,95%CI -6.41至16.12)。自我管理具成本效果(增量净货币效益2240英镑)。结论认为自我管理是有效且具成本效果的长期选择。
要点
- 四年时PFIQ-7自我管理组均值32.9 vs 门诊护理组31.4,校正均值差4.86(95%CI -6.41至16.12),无统计学显著差异。
- 子宫托并发症自我管理组17.7% vs 门诊护理组22.0%,校正均值差3.01(95%CI -0.58至6.61),未达统计学显著。
- 四年时自我管理具成本效果,增量净货币效益为2240英镑。
核心结论
- 子宫托自我管理是盆腔器官脱垂女性有效且具成本效果的长期选择。
研究设计与样本
- TOPSY试验为随机优效性试验的四年问卷随访,在英国子宫托门诊开展。
- 纳入招募时年龄≥18岁、使用子宫托(除外Shelf、Gellhorn或Cube)且已留置≥2周者;排除手部灵活性受限、认知缺陷、妊娠及需要非英语自我管理教学者。
- 共340名女性随机,自我管理组169例、门诊护理组171例;四年时186例(55%)应答(自我管理组86/169[51%],门诊护理组100/171[58%])。
- 自我管理组接受30分钟教学课程、信息传单、2周随访电话及电话支持;门诊护理组接受常规预约。
- 分配通过远程网络应用进行,按年龄、使用者类型(新/现有)和中心最小化,无盲法;主要分析为意向性治疗。
主要发现
- 四年时PFIQ-7无统计学显著组间差异(自我管理组均值32.9 vs 门诊护理组31.4,校正均值差4.86,95%CI -6.41至16.12)。
- 子宫托并发症百分比自我管理组17.7% vs 门诊护理组22.0%,校正均值差3.01(95%CI -0.58至6.61),统计学不显著。
- 四年时自我管理具成本效果,增量净货币效益为2240英镑。
- 自我管理组发生1例可能相关的严重不良事件。
临床怎么用
- 原文结论认为子宫托自我管理是盆腔器官脱垂女性有效且具成本效果的长期选择。
局限性
- 四年时仅186/340(55%)应答,自我管理组应答86/169(51%)、门诊护理组应答100/171(58%)。
- 分配无盲法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare long-term clinical and cost-effectiveness of pessary self-management (SM) with clinic-based care (CBC) for pelvic floor-specific quality of life (QoL). DESIGN: Four-year questionnaire follow-up of trial participants. SETTING: UK pessary clinics. SAMPLE: Responders at 4 years aged ≥ 18 years at recruitment, using a pessary (except Shelf, Gellhorn or Cube) which had been retained ≥ 2 weeks. EXCLUSIONS: limited manual dexterity; cognitive deficit; pregnancy; requiring non-English SM teaching. METHODS: SM group received a 30-min teaching session; information leaflet; 2-week follow-up call; and telephone support. CBC group received routine appointments. Allocation was by remote web-based application, minimised on age, user type (new/existing) and centre with no blinding. Participants were invited to opt into a 4-year follow-up. The primary analysis was intention to treat. OUTCOME MEASURES: The primary outcomes were pelvic floor-specific QoL (PFIQ-7) and incremental net monetary benefit (INB) 4 years post-randomisation. Secondary outcomes included complications and prolapse symptoms. RESULTS: Of 340 women randomised, 186 (55%) responded at 4 years (86/169 [51%] SM, 100/171 [58%] CBC). There was no statistically significant group difference in PFIQ-7 at 4 years (mean SM 32.9 vs. CBC 31.4, adjusted mean difference [AMD] SM-CBC 4.86, 95% CI -6.41 to 16.12). There was a statistically non-significant lower percentage of pessary complications for SM (SM 17.7% vs. CBC 22.0%, AMD 3.01 CI -0.58 to 6.61). At 4-years, SM was cost-effective (INB £2240). There was one potentially related serious adverse event (SM group). CONCLUSIONS: Pessary self-management is an effective and cost-effective long-term option for women with prolapse. TRIAL REGISTRATION: ISRCTN number: 62510577 (https://doi.org/10.1186/ISRCTN62510577).
引用
- Bugge C, Kearney R, Best C, et al. Four Year Clinical and Cost Effectiveness of Vaginal Pessary Self-Management Versus Clinic-Based Care for Pelvic Organ Prolapse (TOPSY): Long Term Follow-Up of a Randomised Controlled Superiority Trial. BJOG. 2025. PMID: 40832737. doi:10.1111/1471-0528.18333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。